Current Report Filing (8-k)

0000874710 false 0000874710 2021-11-11 2021-11-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)
November 11, 2021

 

ALLIED HEALTHCARE PRODUCTS, INC.
(Exact name of registrant as specified in its charter)

 

Delaware	0-19266	25-1370721
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

 

1720 Sublette Avenue, St. Louis, Missouri (Address of principal executive offices)

63110 (Zip Code)

 

Registrant’s telephone number, including area code

[phone]

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging Growth Company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class	Trading Symbol	Name of Each Exchange on Which Registered
Common Stock, $.01	AHPI	The NASDAQ Stock Market, LLC

 

 

 

 

 

 

ITEM 5.07. Submission of Matters to a Vote of Security Holders.

 

The annual meeting of the stockholders of Allied Healthcare Products, Inc. (the “Company”) was held on November 11, 2021. Proxies were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934. There was no solicitation in opposition to management’s nominees for Directors. The voting results are noted below.

 

ELECTION OF DIRECTORS

 

All nominees for Directors were elected with the following votes cast:

 

		For		Withheld		Broker Non-Votes
Susan E. Deuser		1,044,395		66,209		1,149,990
Judith T. Graves		1,044,387		66,217		1,149,990
Joseph F. Ondrus		1,057,034		53,570		1,149,990
Joseph E. Root		1,043,394		63,210		1,153,990
John D. Weil		1,035,535		75,069		1,149,990

 

Agenda Item 2, concerning the ratification of the appointment of RubinBrown LLP as the Company’s independent registered public accounting firm for fiscal 2022 was approved by the stockholders with the following votes cast:

 

For		Against		Abstain
2,168,895		88,543		3,155

 

Agenda Item 3, an advisory (non-binding) vote to approve our executive compensation was approved by the stockholders with the following votes cast:

 

For		Against		Abstain		Broker Non-Votes
948,749		152,807		9,048		1,149,991

 

 

 

 

  

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	ALLIED HEALTHCARE PRODUCTS, INC.
Date:  November 12, 2021	By:	/s/  Daniel C. Dunn
		Daniel C. Dunn
		Chief Financial Officer